RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
-14.76%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$1.19B
AUM Growth
+$1.19B
(-9.5%)
Cap. Flow
+$120M
Cap. Flow
% of AUM
10.08%
Top 10 Holdings %
Top 10 Hldgs %
29.09%
Holding
132
New
11
Increased
77
Reduced
4
Closed
5
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$10.9M |
| 2 |
WBA
Walgreens Boots Alliance
WBA
|
$10.4M |
| 3 |
Edwards Lifesciences
EW
|
$6.7M |
| 4 |
Alkermes
ALKS
|
$6.65M |
| 5 |
RDUS
Radius Health, Inc.
RDUS
|
$6.63M |
Top Sells
| 1 |
Idexx Laboratories
IDXX
|
$9.3M |
| 2 |
RLYP
RELYPSA INC COM
RLYP
|
$7.14M |
| 3 |
AbbVie
ABBV
|
$5.18M |
| 4 |
DYAX
DYAX CORPORATION
DYAX
|
$4.67M |
| 5 |
Travere Therapeutics
TVTX
|
$2.1M |
Sector Composition
| 1 | Healthcare | 77.92% |
| 2 | Financials | 3.87% |
| 3 | Industrials | 0.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AET
1
DELISTED
Aetna Inc
AET
| $46.2M | 3.87% | 411,000 | – | – |
|
|
AGN
2
DELISTED
Allergan plc
AGN
| $45.8M | 3.84% | 171,000 +9,000 | +6% | +$2.41M |
|
3
Acadia Healthcare
ACHC
$2.12B
| $41.3M | 3.46% | 749,500 +74,500 | +11% | +$4.11M |
|
4
HCA Healthcare
HCA
$94.5B
| $33.6M | 2.81% | 430,000 | – | – |
|
|
BXLT
5
DELISTED
BAXALTA INC COM STK (DE)
BXLT
| $32.7M | 2.74% | 810,000 | – | – |
|
|
ALXN
6
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $31.7M | 2.66% | 227,750 +34,750 | +18% | +$4.84M |
|
7
Pfizer
PFE
$141B
| $30.8M | 2.58% | 1,038,300 +63,300 | +6% | +$1.88M |
|
8
Gilead Sciences
GILD
$140B
| $30.3M | 2.54% | 330,300 +5,000 | +2% | +$459K |
|
|
AAAP
9
DELISTED
Advanced Accelerator Applications S.A. American Depositary Shares
AAAP
| $29.2M | 2.44% | 833,000 +33,000 | +4% | +$1.16M |
|
|
RDUS
10
DELISTED
Radius Health, Inc.
RDUS
| $25.4M | 2.13% | 808,500 +211,000 | +35% | +$6.63M |
|
11
Intuitive Surgical
ISRG
$170B
| $25.2M | 2.12% | 42,000 +2,500 | +6% | +$1.5M |
|
|
CELG
12
DELISTED
Celgene Corp
CELG
| $24M | 2.01% | 239,500 +9,500 | +4% | +$951K |
|
|
WCG
13
DELISTED
Wellcare Health Plans, Inc.
WCG
| $21.3M | 1.79% | 230,000 +15,500 | +7% | +$1.44M |
|
14
Teva Pharmaceuticals
TEVA
$21.1B
| $21.1M | 1.77% | 395,000 +15,700 | +4% | +$840K |
|
15
Collegium Pharmaceutical
COLL
$1.22B
| $20.8M | 1.74% | 1,145,000 +139,513 | +14% | +$2.53M |
|
|
MDCO
16
DELISTED
Medicines Co
MDCO
| $20.1M | 1.68% | 632,000 +7,000 | +1% | +$222K |
|
17
Eli Lilly
LLY
$657B
| $19.9M | 1.67% | 276,000 +103 | +0% | +$7.42K |
|
18
Pacira BioSciences
PCRX
$1.2B
| $17.3M | 1.45% | 326,500 +66,500 | +26% | +$3.52M |
|
|
ONCE
19
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $17.1M | 1.44% | 580,500 +20,500 | +4% | +$605K |
|
20
Aclaris Therapeutics
ACRS
$209M
| $17M | 1.42% | 895,500 -654 | -0.1% | -$12.4K |
|
21
Elevance Health
ELV
$71.8B
| $16.8M | 1.41% | 121,000 +200 | +0.2% | +$27.8K |
|
22
Cigna
CI
$80.3B
| $16.7M | 1.4% | 122,000 | – | – |
|
|
TSRO
23
DELISTED
TESARO, Inc.
TSRO
| $16.7M | 1.4% | 379,500 +45,500 | +14% | +$2M |
|
24
Neurocrine Biosciences
NBIX
$13.8B
| $16M | 1.34% | 404,500 +27,000 | +7% | +$1.07M |
|
25
Thermo Fisher Scientific
TMO
$186B
| $14.2M | 1.19% | 100,200 +200 | +0.2% | +$28.3K |
|